詳細検索

詳細検索

お問い合わせ

Cell Harvester Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Displacement Collector, Therapy Collector), By Application (Cell Proliferation Assays, Mixed Lymphocyte Culture (MLC) Assays, Receptor-Binding Assays, Single-Stranded Template DNA Harvesting, Others), By Region & Competition, 2021-2031F

Cell Harvester Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Displacement Collector, Therapy Collector), By Application (Cell Proliferation Assays, Mixed Lymphocyte Culture (MLC) Assays, Receptor-Binding Assays, Single-Stranded Template DNA Harvesting, Others), By Region & Competition, 2021-2031F


Market Overview The Global Cell Harvester Market is expected to experience a compound annual growth rate (CAGR) of 6.61%, expanding from USD 3.78 billion in 2025 to USD 5.55 billion by 2031. These... もっと見る

 

 

出版社
TechSci Research
テックサイリサーチ
出版年月
2026年5月1日
電子版価格
US$4,500
シングルユーザーライセンス
ライセンス・価格情報/注文方法はこちら
納期
PDF:2営業日程度
ページ数
182
言語
英語

英語原文をAIを使って翻訳しています。


 

Summary

Market Overview
The Global Cell Harvester Market is expected to experience a compound annual growth rate (CAGR) of 6.61%, expanding from USD 3.78 billion in 2025 to USD 5.55 billion by 2031. These vital devices are built to effectively separate, gather, and process cells from biological materials for various therapeutic and research purposes. Market growth is primarily fueled by rising needs in regenerative medicine, a rapidly expanding biopharmaceutical sector, and the wider use of cell-based treatments for infectious and chronic conditions. Furthermore, progress in closed-system and automated technologies greatly improves processing precision and efficiency. The magnitude of the supporting industry is highlighted by the Biotechnology Innovation Organization (BIO), which estimated the wider bioscience product market at $1.7 trillion in 2025.
Despite these positive trends, market growth faces a major obstacle due to the steep expenses tied to cutting-edge cell harvesting equipment and related procedures. This financial barrier encompasses both the initial capital required for complex automated platforms and the ongoing operational costs for trained staff and specialized disposable materials.
Market Driver
The Global Cell Harvester Market is largely driven by the rapid growth of cell therapies and regenerative medicine. These cutting-edge treatments rely heavily on effective cell harvesting techniques to isolate and process specific cells for combating diseases. The need for dependable and adaptable cell processing methods grows stronger as an increasing number of gene and cell therapies move toward clinical trials and regulatory clearance. Ensuring optimal cell purity and survival, harvesters are indispensable for readying cells for transplantation and infusion. Emphasizing the massive pipeline in need of sophisticated processing tools, PhRMA reported that 438 gene and cell therapies were actively being developed in the United States as of January 2026.
The market is also heavily influenced by breakthroughs in single-use and automated technologies. Automation lowers contamination threats, boosts consistency, and cuts down on manual work, all of which are essential for producing delicate cell therapies. Utilizing single-use elements like disposable tubing and bags streamlines procedures, speeds up processing cycles, and mitigates cross-contamination hazards by removing the need for rigorous sterilization and cleaning. Showcasing a strong commitment to bioprocessing that aids cell harvesting, European Biotechnology Magazine noted in February 2026 that Sartorius dedicated EUR 442 million in 2025 to expand production in Asia and Europe. Additionally, Biocom reported in March 2026 that the life science industry saw a total deal value of $372 billion in 2025, reflecting the extensive sectoral expansion driving the need for new harvesting technologies.
Market Challenge
A major barrier to the growth of the Global Cell Harvester Market is the steep price of modern cell harvesting equipment and the corresponding procedural expenses. Buyers face heavy initial capital requirements to purchase the automated platforms needed for effective cell gathering and isolation. Moreover, the continuous operational costs tied to expert personnel, reagents, and specialized disposable supplies significantly increase the financial strain on users. Such steep economic requirements restrict wider market penetration, especially for academic labs, smaller research facilities, and nascent biopharmaceutical firms operating on tight budgets.
The massive financial scope of advanced therapies is reflected in the heavy investments needed throughout the regenerative medicine industry, directly affecting the uptake of niche devices like cell harvesters. The Alliance for Regenerative Medicine reported that the sector raised $11.1 billion through 216 financing rounds in 2025. High expenses associated with harvesting technologies form a major part of the capital needed to build and run research and manufacturing centers for cell therapies. Consequently, this financial reality hinders market expansion, forcing organizations to carefully balance large upfront costs against their operating budgets and expected returns.
Market Trends
Within the Global Cell Harvester Market, the growing robust pipeline of gene and cell therapies is creating a strong demand for high-throughput processing capabilities. This movement highlights the necessity to handle larger volumes of cell populations and samples at the same time, which greatly quickens the pace of research, development, and commercial manufacturing. High-throughput harvesting technologies facilitate smoother operational workflows, which are essential for scaling up effectively and maintaining uniformity across massive production batches. Illustrating this shift toward scaled operations, News on Projects highlighted in February 2026 that Cytiva launched a 30,000-square-foot bioprocessing plant in Bengaluru, India, aimed at speeding up biopharmaceutical drug development.
At the same time, cell harvesting is being revolutionized by the incorporation of digital monitoring systems and artificial intelligence, leading to better operational efficiency and accuracy. Moving away from standard manual checks, digital instruments and AI algorithms allow for the real-time assessment of optimal harvesting times, growth metrics, and overall cell health. By predicting process anomalies, lowering human error, and maximizing cell survival and yield, these advancements elevate the reproducibility and quality of the final product. Highlighting this trend, Emory University announced in December 2025 the implementation of a $1.5 million automated cell culture platform that uses AI to concurrently track and analyze 20,000 organoids for cell differentiation trends.

Key Market Players
* Human Med AG
* ADS Biotec Inc.
* PerkinElmer Inc.
* TERUMO BCT, INC.
* Esco Micro Pte. Ltd.
* Gasser Apparatebau und Laborzubeh?r
* Sartorius AG
* Cox Scientific Ltd.
* Pall Corporation

Report Scope
In this report, the Global Cell Harvester Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

# Cell Harvester Market, By Type
* Displacement Collector
* Therapy Collector
# Cell Harvester Market, By Application
* Cell Proliferation Assays
* Mixed Lymphocyte Culture (MLC) Assays
* Receptor-Binding Assays
* Single-Stranded Template DNA Harvesting
* Others
# Cell Harvester Market, By Region
* North America
United States
Canada
Mexico
* Europe
France
United Kingdom
Italy
Germany
Spain
* Asia Pacific
China
India
Japan
Australia
South Korea
* South America
Brazil
Argentina
Colombia
* Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Cell Harvester Market.
Available Customizations:
Global Cell Harvester Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
* Detailed analysis and profiling of additional market players (up to five).

ページTOPに戻る


Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Cell Harvester Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (Displacement Collector, Therapy Collector)
5.2.2. By Application (Cell Proliferation Assays, Mixed Lymphocyte Culture (MLC) Assays, Receptor-Binding Assays, Single-Stranded Template DNA Harvesting, Others)
5.2.3. By Region
5.2.4. By Company (2025)
5.3. Market Map
6. North America Cell Harvester Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By Application
6.2.3. By Country
6.3. North America: Country Analysis
6.3.1. United States Cell Harvester Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type
6.3.1.2.2. By Application
6.3.2. Canada Cell Harvester Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type
6.3.2.2.2. By Application
6.3.3. Mexico Cell Harvester Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type
6.3.3.2.2. By Application
7. Europe Cell Harvester Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Application
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Cell Harvester Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By Application
7.3.2. France Cell Harvester Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By Application
7.3.3. United Kingdom Cell Harvester Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By Application
7.3.4. Italy Cell Harvester Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type
7.3.4.2.2. By Application
7.3.5. Spain Cell Harvester Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type
7.3.5.2.2. By Application
8. Asia Pacific Cell Harvester Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Application
8.2.3. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Cell Harvester Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By Application
8.3.2. India Cell Harvester Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By Application
8.3.3. Japan Cell Harvester Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By Application
8.3.4. South Korea Cell Harvester Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type
8.3.4.2.2. By Application
8.3.5. Australia Cell Harvester Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type
8.3.5.2.2. By Application
9. Middle East & Africa Cell Harvester Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Application
9.2.3. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Cell Harvester Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Application
9.3.2. UAE Cell Harvester Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By Application
9.3.3. South Africa Cell Harvester Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By Application
10. South America Cell Harvester Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type
10.2.2. By Application
10.2.3. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Cell Harvester Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type
10.3.1.2.2. By Application
10.3.2. Colombia Cell Harvester Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type
10.3.2.2.2. By Application
10.3.3. Argentina Cell Harvester Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type
10.3.3.2.2. By Application
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Cell Harvester Market: SWOT Analysis
14. Porter's Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Human Med AG
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. ADS Biotec Inc.
15.3. PerkinElmer Inc.
15.4. TERUMO BCT, INC.
15.5. Esco Micro Pte. Ltd.
15.6. Gasser Apparatebau und Laborzubeh?r
15.7. Sartorius AG
15.8. Cox Scientific Ltd.
15.9. Pall Corporation
16. Strategic Recommendations
17. About Us & Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医療)の最新刊レポート

TechSci Research社の ヘルスケア分野 での最新刊レポート

本レポートと同じKEY WORD(industry)の最新刊レポート


よくあるご質問


TechSci Research社はどのような調査会社ですか?


テックサイリサーチ(TechSci Research)は、カナダ、英国、インドに拠点を持ち、化学、IT、環境、消費財と小売、自動車、エネルギーと発電の市場など、多様な産業や地域を対象とした調査・出版活... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。


詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

 

2026/05/21 10:25

159.96 円

186.32 円

217.66 円

ページTOPに戻る